Search

Abstract Background & aim: Glaucium flavum is used as an anti-diabetes herb in traditional medicine in the southern regions of Iran. Regarding the widespread secondary complications of diabetes, including nephropathy and hepatopathy. The present study was conducted to compare the effects of glacial auricularis and glibenclamide on the changes in serum levels of blood urea nitrogen, creatinine and total and direct bilirubin in alloxan-induced diabetic rats. Methods: In the present experimental study, 40 adult male Wistar rats were randomly divided into five equal groups: control, diabetic control, diabetic treatment with 250 mg / kg glaucium flavum extract, diabetic treated with mentioned extract with daily dose of 500 mg / kg and diabetic treatment with glibenclamide at daily dose of 5 μg / kg. Groups 2 to 5 received single dose (120 mg / kg) of alloxan. After thirty days, the animals were anesthetized and blood samples were taken from the heart. Creatinine, urea nitrogen, totals and direct bilirubin were measured by enzymatic method. The obtained cultivars were analyzed by one-way ANOVA and Tukey's post-hoc test. Results: A significant differences was seen between the means of 250 treated group and diabetic control group among all four factors (P0.05), this reduction for the drug treated group was limited to creatinine and total bilirubin. Conclusion: It could be concluded that the oral administration of the aqueous extracts may help to improve the activity of liver and kidney cleansing of diabetic rats by using anti-inflammatory properties of its compounds, including glucosin, as well as the anti-oxidant effects of Berberine.

Background: Restless leg syndrome (RLS) is a sensory-motor disorder that affects 6-83% of dialysis patients. Increased Urea and creatinine, and Iron deficiency anemia resulting from renal failure are some causes of restless leg syndrome. This study was aimed to evaluate this issue. Methods: A cross sectional study was done on 130 dialysis patients in 5 dialysis centers of Bushehr Province. The diagnosis of RLS was made using the criteria of the International Restless Leg syndrome. The length of renal failure, number of weekly dialysis, erythropoietin dose per week, dose of mineral Iron per day, other co morbidities and medications, ferritin level, and predialysis BUN were determined. Results: In this study 43 (33.1%) patients had restless leg syndrome who consisted of 18 (41.9%) women and 25 (58.1%) men. Positive family history was significantly associated with restless leg syndrome (p

Background & Objective: More than 50% of patients with hypertension will have end organ damage (such as: CHF, retinopathy ,CVA or renal failure).Left ventricular hypertrophy (LVH) is an independent risk factor for death and cardiovascular disease .Both renal dysfunction and LVH are signs of end organ damage so we carried out this study to evaluate the correlation between LVH in echocardiography and kidney function in patients with essential hypertension. Materials & Methods: This descriptive analytic study was carried out on 102 patients whome reffered to 5 Azar hospital in Gorgan- Iran, suffering from essential hypertension and had proved LVH in echocardiography with no other disease during 2005-6. Kidney and urinary tract assessment such as serum BUN, Creatinine level and kidney sonography was done on subjects. Left ventricular hypertrophy was defined as a left ventricular mass index (LVMI)>=135g/m2 in men and>=110g/m2 in women. Renal function was estimated by means of the serum Creatinine level and proteinuria and sonographic findings of kidney and urinary tract. Data was analysed by Spss-11.5 and Chi-Squre test. Results: The average age of patients were 60±8.8. 58%, 36% and 7% of patients had mild, moderate and sever LVH respectivly. The means of Creatinine and BUN level were 1.09±1.12 mg/dl and 20.6±10.76 mg/dl had direct correlation with kidney dysfunction (P

Background and Objectives: Regarding to the increasing of zinc oxide-iron-nickel nanoparticles and their applications in the biological systems, it seems that there are less investigations on their side effects in the organisms. In this research the effect of Fe4NiO4Zn nanoparticles on renal function was investigated. Materials and Methods: Twenty four Wistar rat were studied. They were divided into three groups: 1) control group (2,3) treated groups, These groups received. . /5cc of saline, /5cc of solution containing 100, 200 ppm Fe2NiO4 for 7 successive days, respectively. Then renal parameters such as uric acid, creatinine and BUN (blood urea nitrogen) were evaluated at (2,7 and 14 days). Results: Mean uric acid levels, at 7 day after the intervention, were significantly increased in both doses. Also, in group 2 (Fe4NiO4Zn 100 ppm), mean uric acid, levels at 7, 14 day after the intervention were significantly increased. Mean BUN levels showed significant decrease in comparison with control group (at 2-7-14 days) in both doses. In high dose (Fe4NiO4Zn 200 ppm), mean creatinine levels showed significant decrease. Conclusion: Results of this study showed that Fe4NiO4Zn can influence the renal function. The difference in tissue distribution, penetration, and damage of nanoparticles in various studies is probably due to the difference in their synthesis method that leads to the changes in size, shape, and other physical and chemical properties of nanoparticles. It seems that the application of Fe4NiO4Zn nanoparticles in the biological system has no stable and long-term toxic effects on the animal body. Probably the reticuloendothelial system excretes the nanoparticles from the body. [ABSTRACT FROM AUTHOR]